IRIS
LOPALCO, GIUSEPPE
 Distribuzione geografica
Salva come PNG Salva come JPEG
Continente #
NA - Nord America 10.134
AS - Asia 4.252
EU - Europa 3.885
SA - Sud America 1.065
AF - Africa 198
Continente sconosciuto - Info sul continente non disponibili 8
OC - Oceania 5
Totale 19.547
Salva come PNG Salva come JPEG
Nazione #
US - Stati Uniti d'America 9.903
SG - Singapore 1.821
IT - Italia 1.502
CN - Cina 849
BR - Brasile 833
HK - Hong Kong 481
FR - Francia 466
SE - Svezia 443
RU - Federazione Russa 434
DE - Germania 338
VN - Vietnam 300
FI - Finlandia 202
GB - Regno Unito 196
BD - Bangladesh 171
IN - India 147
CA - Canada 104
AR - Argentina 87
IQ - Iraq 75
ID - Indonesia 68
MX - Messico 68
TR - Turchia 58
ZA - Sudafrica 58
CI - Costa d'Avorio 49
ES - Italia 49
JP - Giappone 47
PK - Pakistan 43
CO - Colombia 35
BE - Belgio 34
EC - Ecuador 33
NL - Olanda 31
SA - Arabia Saudita 30
PL - Polonia 29
UA - Ucraina 28
VE - Venezuela 27
UZ - Uzbekistan 26
AT - Austria 24
MA - Marocco 22
CZ - Repubblica Ceca 21
CL - Cile 19
LT - Lituania 18
PH - Filippine 18
MY - Malesia 15
IE - Irlanda 14
PY - Paraguay 14
JM - Giamaica 12
TN - Tunisia 12
KE - Kenya 11
IR - Iran 10
NP - Nepal 10
EG - Egitto 9
CH - Svizzera 8
CR - Costa Rica 7
DO - Repubblica Dominicana 7
EU - Europa 7
HN - Honduras 7
JO - Giordania 7
KZ - Kazakistan 7
UY - Uruguay 7
AM - Armenia 6
AZ - Azerbaigian 6
DZ - Algeria 6
ET - Etiopia 6
PA - Panama 6
PE - Perù 6
PT - Portogallo 6
QA - Qatar 6
AE - Emirati Arabi Uniti 5
HR - Croazia 5
KG - Kirghizistan 5
NI - Nicaragua 5
OM - Oman 5
SI - Slovenia 5
SN - Senegal 5
TH - Thailandia 5
TT - Trinidad e Tobago 5
BH - Bahrain 4
IL - Israele 4
LB - Libano 4
RS - Serbia 4
AU - Australia 3
BB - Barbados 3
BO - Bolivia 3
GE - Georgia 3
HU - Ungheria 3
NG - Nigeria 3
PS - Palestinian Territory 3
RO - Romania 3
AF - Afghanistan, Repubblica islamica di 2
AL - Albania 2
BG - Bulgaria 2
BS - Bahamas 2
DK - Danimarca 2
GA - Gabon 2
GH - Ghana 2
LU - Lussemburgo 2
LV - Lettonia 2
LY - Libia 2
MD - Moldavia 2
ML - Mali 2
MM - Myanmar 2
Totale 19.510
Salva come PNG Salva come JPEG
Città #
Ashburn 1.108
Fairfield 1.070
Singapore 997
Woodbridge 693
Houston 658
San Jose 592
Chandler 574
Milan 568
Hong Kong 476
Seattle 451
Ann Arbor 390
Cambridge 387
Nyköping 364
Wilmington 329
Beijing 320
Dallas 218
Lauterbourg 186
Los Angeles 173
New York 163
Rome 155
Lawrence 125
Roxbury 120
Bari 115
Munich 112
Columbus 110
Helsinki 106
São Paulo 92
Ho Chi Minh City 91
Santa Clara 88
Jacksonville 85
Des Moines 79
Falkenstein 78
Boardman 77
Buffalo 77
Nanjing 77
Moscow 67
Council Bluffs 65
Inglewood 64
Princeton 58
Brooklyn 57
Hanoi 57
Figino 51
Abidjan 49
London 49
San Diego 45
Chicago 44
Turku 42
Paris 39
Jakarta 37
Frankfurt am Main 36
Johannesburg 36
Tokyo 36
Shenyang 35
Brussels 33
Turin 32
Atlanta 29
Denver 29
Montreal 29
Bar Harbor 28
Dearborn 28
San Francisco 28
Belo Horizonte 27
Baghdad 26
Mexico City 25
Phoenix 25
Warsaw 25
Toronto 24
Boston 23
Dong Ket 23
Orem 23
Rio de Janeiro 23
Manchester 22
Tashkent 22
Brasília 20
Nanchang 20
Pune 20
Chennai 19
Naples 19
Poplar 19
The Dalles 18
Dhaka 16
Jiaxing 16
Stockholm 16
Redwood City 15
Da Nang 14
Dublin 14
Guangzhou 14
Lahore 14
Salt Lake City 14
Tianjin 14
Changsha 13
Curitiba 13
Hebei 13
Nuremberg 13
Shanghai 13
Amsterdam 12
Campinas 12
Vienna 12
Bologna 11
Goiânia 11
Totale 13.100
Salva come PNG Salva come JPEG
Nome #
Explainable artificial intelligence for microbiome data analysis in colorectal cancer biomarker identification 229
Safety of Long-Term Biologic Therapy in Rheumatologic Patients With a Previously Resolved Hepatitis B Viral Infection 208
Sarcopenia in Patients with Rheumatic Diseases: Prevalence and Associated Risk Factors 207
AB0836 Drug retention rate of the first tnf inhibitor in radiographic and non radiographic axial spondyloarthritis: data from a multicenter study 198
Correlation between serum amyloid-A and serum levels of proinflammatory cytokines in patients with Behçet's disease 191
A Bayesian mixed treatment comparison of efficacy of biologics and small molecules in early rheumatoid arthritis 186
Basic characteristics of adults with periodic fever, aphthous stomatitis, pharyngitis, and adenopathy syndrome in comparison with the typical pediatric expression of disease 186
AB0065 Possible Interplay Between Serum Amyloid-A and Pro-Inflammatory Cytokines Into the Pathogenesis of Behçet's Disease 185
Adalimumab Accounts for Long-Term Control of Noninfectious Uveitis Also in the Absence of Concomitant DMARD Treatment: A Multicenter Retrospective Study 182
A false occult hepatitis B virus infection developed in a patient with psoriatic arthritis under infliximab and methotrexate therapy 179
AB0452 Changes in Lipoproteins Associated with Tocilizumab Treatment Do not Influence the Atherogenic Index of Plasma of Rheumatoid Arthritis Patients: Table 1 178
Effectiveness and tuberculosis-related safety profile of interleukin-1 blocking agents in the management of Behçet's disease 177
AB0041 Serum Amyloid A Stimulates The Induction of Inflammatory Mediators in Monocytes from Behçet's Disease Patients: A Proof of Concept Study 175
Retinal vessels thrombosis as onset manifestation of systemic sclerosis: 3 clinical cases 172
Efficacy and safety profile of anti-interleukin-1 treatment in Behçet’s disease: a multicenter retrospective study 171
Mucocutaneous Involvement in Behçet's Disease: How Systemic Treatment Has Changed in the Last Decades and Future Perspectives 170
Interleukin-1 as a common denominator from autoinflammatory to autoimmune disorders: Premises, perils, and perspectives 168
Lipids and atherogenic indices fluctuation in rheumatoid arthritis patients on long-term tocilizumab treatment 167
Refractory knee giant cell tumor of the synovial membrane treated with intra-articular injection of Infliximab: A case series and review of the literature 165
SAT0216 Chest Ultrasound Signs of Interstitial Lung Disease in Systemic Sclerosis Patients: A Comparison between High Resolution Chest Computed Tomography Findings 164
Unveiling the Efficacy, Safety, and Tolerability of Anti-Interleukin-1 Treatment in Monogenic and Multifactorial Autoinflammatory Diseases 162
AB0369 Adult-onset still’s disease treatment predictors at 1-year follow-up in a single rheumatologic centre experience 158
Paradoxical mucocutaneous flare in a case of Behçet’s disease treated with tocilizumab 155
Different switching rate of anti-TNF-α drugs in monotherapy and in combination with methotrexate in a cohort of rheumatoid arthritis patients in the real life 152
Autoimmunity and autoinflammation as the yin and yang of idiopathic recurrent acute pericarditis 152
Interleukin (IL)-1 inhibition with anakinra and canakinumab in Behçet's disease-related uveitis: a multicenter retrospective observational study 151
Auditory involvement in Behcet’s disease: relationship with demographic, clinical, and therapeutic characteristics 151
A comprehensive comparison between pediatric and adult patients with periodic fever, aphthous stomatitis, pharyngitis, and cervical adenopathy (PFAPA) syndrome 149
Cumulative retention rate of adalimumab in patients with Behçet's disease-related uveitis: a four-year follow-up study 149
Comparative efficacy between adalimumab and infliximab in the treatment of non-infectious intermediate uveitis, posterior uveitis, and panuveitis: a retrospective observational study of 107 patients 147
THU0153 The effect of 5-years b-dmards treatment on different 10-years cardiovascular risk scores applied in rheumatoid arthritispatients 147
SAT0212 Pericardial Effusion Related To Systemic Sclerosis: A Possible Contribution of The Serum Levels of Adipokines and Interleukines 146
Tumor necrosis factor receptor-associated periodic syndrome managed with the couple canakinumab-alendronate 144
Proinflammatory cytokines and antiskin autoantibodies in patients with inherited epidermolysis bullosa 142
Serum amyloid-A in Behçet's disease 141
Longterm clinical outcomes in 420 patients with psoriatic arthritis taking anti-tumor necrosis factor drugs in real-world settings 140
PFAPA syndrome and Behçet’s disease: a comparison of two medical entities based on the clinical interviews performed by three different specialists 138
Ten-Year Retention Rate of Infliximab in Patients with Behçet's Disease-Related Uveitis 137
FRI0110 Methotrexate monotherapy in real life: a drug survival analysis. comparison between very early arthritis and early arthritis cohorts 135
Management of Small Vessel Vasculitides 134
Certolizumab Pegol treatment in Behcet's disease with different organ involvement: A multicenter retrospective observational study 132
Untangling the web of systemic autoinflammatory diseases 132
A convolutional neural network with transfer learning for automatic discrimination between low and high-grade synovitis: a pilot study 131
Key facts and hot spots on tumor necrosis factor receptor-associated periodic syndrome 130
AB0245 PREDICTORS OF BIOLOGIC THERAPY DISCONTINUATION IN RHEUMATOID ARTHRITIS PATIENTS AFTER REMISSION ACHIEVEMENT: A MONOCENTRIC OBSERVATIONAL STUDY FROM BIOLOGIC APULIAN REGISTRY (BIOPURE) 129
OP0129 Drug survival on anti-tnf-alpha in psoriatic arthritis patients with axial involvement and analysis of predictors 129
Critical regulation of Th17 cell differentiation by serum amyloid-A signalling in Behcet's disease 128
Splenic Infarction as Only Manifestation of Antiphospholipid Syndrome in a Patient With Rheumatoid Arthritis 128
Improvement of Refractory Dysphagia in Patients with Idiopathic Inflammatory Myopathies Receveing Immunoglobulin Intravenous Therapy 127
Behçet's syndrome in Italy: a detailed retrospective analysis of 396 cases seen in 3 tertiary referral clinics 125
Efficacy of adalimumab and infliximab in recalcitrant retinal vasculitis inadequately responsive to other immunomodulatory therapies 124
Efficacy and safety of adalimumab in Behçet's disease-related uveitis: a multicenter retrospective observational study. 123
A Machine Learning Approach to Predict Remission in Patients With Psoriatic Arthritis on Treatment With Secukinumab 122
Mepolizumab for Eosinophilic Granulomatosis With Polyangiitis: A European Multicenter Observational Study 122
Long-term retention rate of anakinra in adult onset Still’s disease and predictive factors for treatment response 121
Different roles of TNF inhibitors in acute anterior uveitis associated with ankylosing spondylitis: state of the art 118
Systemic Steroid Sparing Effect of Intravitreal Dexamethasone Implant in Chronic Noninfectious Uveitic Macular Edema 118
THU0168 Relationships between body fat composition assessed with bioelectrical impedance analysis, serum adipokines and disease activity in patients with rheumatoid arthritis 118
The autoinflammatory side of recurrent pericarditis: Enlightening the pathogenesis for a more rational treatment 118
Influence of baseline modified Rheumatic Disease Comorbidity Index (mRDCI) on drug survival and effectiveness of biological treatment in patients affected with Rheumatoid arthritis, Spondyloarthritis and Psoriatic arthritis in real-world settings 117
Anakinra for corticosteroid-dependent and colchicine-resistant pericarditis: The IRAP (International Registry of Anakinra for Pericarditis) study 117
The protean ocular involvement in monogenic autoinflammatory diseases: state of the art 117
SAT0380 FIBROMYALGIA IS THE STRONGEST NEGATIVE PREDICTOR FOR THE ACHIEVEMENT OF EITHER REMISSION AND MINIMAL DISEASE ACTIVITY IN NAIVE PSORIATIC ARTHRITIS PATIENTS STARTING BIOLOGIC DRUGS 115
Long-term retention rates of adalimumab and infliximab in non-infectious intermediate, posterior, and panuveitis 115
Pain Processing and Vegetative Dysfunction in Fibromyalgia: A Study by Sympathetic Skin Response and Laser Evoked Potentials 114
Immunogenicity of BNT162b2 mRNA SARS-CoV-2 vaccine in patients with psoriatic arthritis on TNF inhibitors 113
Relapsing Polychondritis: an Update on Pathogenesis, Clinical Features, Diagnostic Tools, and Therapeutic Perspectives 112
The role of biosimilars in uveitis: Long-term real-world outcomes of the switch from original to biosimilar TNF-alpha inhibitors 112
IL-6 blockade in the management of non-infectious uveitis 109
improvement of refractory dysphagia in patients with idiopathic inflammatory myopathies receveing immunoglubulin intravenous therapy 109
Anakinra effectiveness in refractory polyserositis: An Italian multicenter study 108
Different drug survival of first line tumour necrosis factor inhibitors in radiographic and non-radiographic axial spondyloarthritis: a multicentre retrospective survey 108
Adalimumab effectively controls both anterior and posterior noninfectious uveitis associated with systemic inflammatory diseases: focus on Behçet’s syndrome 108
Efficacy and safety of certolizumab pegol and golimumab in the treatment of non-infectious uveitis 107
Development and Implementation of the AIDA International Registry for Patients with Non-Infectious Scleritis 107
Heterogeneous clinical spectrum of interstitial lung disease in patients with anti-EJ anti-synthetase syndrome: a case series 106
Safety profile of biologic agents for Behçet's disease in a multicenter observational cohort study 105
Predictors of sustained clinical response in patients with Behçet’s disease-related uveitis treated with infliximab and adalimumab 105
Influence of changes in cholesterol levels and disease activity on the 10 years cardiovascular risk estimated with different algorithms in rheumatoid arthritis patients 102
High disease relapse after bDMARD spacing in psoriatic arthritis compared to rheumatoid arthritis and axial spondyloarthritis patients: real-life data from BIOPURE registry 102
Comparison of Adalimumab to Other Targeted Therapies in Rheumatoid Arthritis: Results from Systematic Literature Review and Meta-Analysis 101
Putative role of serum amyloid-A and proinflammatory cytokines as biomarkers for behcet's disease 101
Safety profile of the interleukin-1 inhibitors anakinra and canakinumab in real-life clinical practice: a nationwide multicenter retrospective observational study 101
Genetic and clinical features of Familial Mediterranean Fever (FMF) in a homogeneous cohort of patients from south-eastern Italy 99
Plasma pentraxin 3 in idiopathic inflammatory myopathies: a possible new biomarker of disease activity 98
Long-term safety of anti-TNF agents on the liver of patients with spondyloarthritis and potential occult hepatitis B viral infection: an observational multicentre study 98
Development and Implementation of the AIDA International Registry for Patients with Non-Infectious Uveitis 98
Validity of Machine Learning in Predicting Giant Cell Arteritis Flare After Glucocorticoids Tapering 96
Efficacy of baricitinib on refractory skin papulosquamous rash in a patient with systemic lupus erythematosus 96
A Snapshot on the On-Label and Off-Label Use of the Interleukin-1 Inhibitors in Italy among Rheumatologists and Pediatric Rheumatologists: A Nationwide Multi-Center Retrospective Observational Study 95
Complete Hydatidiform Mole Mimicking Sacroiliitis 94
Unraveling the microbiome-metabolome nexus: a comprehensive study protocol for personalized management of Behḉet’s disease using explainable artificial intelligence 92
Risk of acute arterial and venous thromboembolic events in Eosinophilic Granulomatosis with Polyangiitis (Churg-Strauss syndrome) 92
Comorbid fibromyalgia impairs the effectiveness of biologic drugs in patients with psoriatic arthritis 92
Development and preliminary validation of the Behçet’s syndrome Overall Damage Index (BODI) 89
Development and implementation of the AIDA International Registry for patients with Behçet's disease 89
Epidemiological profile of non-infectious uveitis from the rheumatologist's perspective: a survey from two tertiary referral centres in Italy 89
Effectiveness of Tapering Rituximab Dose in Idiopathic Inflammatory Myopathies: Real-World Data from a Monocentric Study 89
Anti-SARS-CoV-2 antibody decay after vaccination and immunogenicity of the booster dose of the BNT162b2 mRNA vaccine in patients with psoriatic arthritis on TNF inhibitors 88
Biological therapies for the treatment of Behçet’s disease-related uveitis beyond TNF-alpha blockade: a narrative review 87
Totale 13.155
Salva come PNG Salva come JPEG
Categoria #
all - tutte 86.150
article - articoli 0
book - libri 0
conference - conferenze 0
curatela - curatele 0
other - altro 0
patent - brevetti 0
selected - selezionate 0
volume - volumi 0
Totale 86.150
Salva come PNG Salva come JPEG


Totale Lug Ago Sett Ott Nov Dic Gen Feb Mar Apr Mag Giu
2021/2022985 73 40 20 42 40 82 67 53 72 81 120 295
2022/20231.547 219 199 128 123 114 241 34 198 207 12 51 21
2023/2024545 41 107 24 44 48 129 18 28 6 15 13 72
2024/20252.950 66 37 197 64 47 279 318 347 151 201 439 804
2025/20268.388 908 311 466 969 1.174 473 793 249 862 847 311 1.025
2026/2027442 442 0 0 0 0 0 0 0 0 0 0 0
Totale 20.518